Market Cap 34.19M
Revenue (ttm) 8.98M
Net Income (ttm) -48.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -543.32%
Debt to Equity Ratio 0.00
Volume 600,000
Avg Vol 361,038
Day's Range N/A - N/A
Shares Out 46.84M
Stochastic %K 3%
Beta 0.74
Analysts Strong Sell
Price Target $3.67

Company Profile

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid S...

Industry: Medical Devices
Sector: Healthcare
Phone: 888 776 6804
Address:
6303 Waterford District Drive, Suite 215, Miami, United States
Capital_Gains_X
Capital_Gains_X Jun. 15 at 3:30 PM
$NSPR volume is way up this morning...
0 · Reply
BioBuddha
BioBuddha Jun. 15 at 3:16 PM
$NSPR lol people are trying to dump a stock that is already in dumpster.
1 · Reply
Thespectator
Thespectator Jun. 15 at 3:15 PM
$NSPR brand new ATL unlocked today, congrats perma bulls!
0 · Reply
HermesHedges
HermesHedges Jun. 15 at 2:32 PM
0 · Reply
Jonnie5
Jonnie5 Jun. 13 at 4:49 AM
$NSPR 5+ year hold of slow Chinese water torture.
1 · Reply
Thespectator
Thespectator Jun. 12 at 10:09 PM
$NSPR hah every pr was solely benefitting the great management team, surely they deserve every penny!
0 · Reply
arcuy
arcuy Jun. 12 at 9:49 PM
$NSPR sold everything. Hold this since 2019-2020. Not anymore
2 · Reply
focafoca99
focafoca99 Jun. 12 at 8:23 PM
$NSPR grants inducement stock awards to six new non-executive employees under Nasdaq Rule 5635(c)(4). https://www.rapidticker.com/news/nspr-inspiremd-announces-inducement-grants-under-380010
0 · Reply
Jackedtothetits42
Jackedtothetits42 Jun. 11 at 2:21 PM
$NSPR amazing results, will still be red eod
0 · Reply
focafoca99
focafoca99 Jun. 11 at 1:21 PM
$NSPR initiated a 30‑day results update from the CGUARDIANS II trial, showing 100% acute device success and zero major adverse events. https://www.rapidticker.com/news/nspr-inspiremd-announces-30-day-results-d039a7
0 · Reply
Latest News on NSPR
InspireMD enrolls first patient in CGUARDIANS III study

2026-06-08T12:07:53.000Z - 7 days ago

InspireMD enrolls first patient in CGUARDIANS III study


InspireMD price target lowered to $3 from $4 at Piper Sandler

2026-05-05T11:00:54.000Z - 5 weeks ago

InspireMD price target lowered to $3 from $4 at Piper Sandler


InspireMD reports Q1 EPS (16c), consensus (18c)

2026-05-04T20:44:33.000Z - 6 weeks ago

InspireMD reports Q1 EPS (16c), consensus (18c)


InspireMD Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 6 weeks ago

InspireMD Earnings Call Transcript: Q1 2026


InspireMD Earnings release: Q1 2026

May 4, 2026, 4:30 PM EDT - 6 weeks ago

InspireMD Earnings release: Q1 2026


InspireMD Quarterly report: Q1 2026

May 4, 2026, 4:30 PM EDT - 6 weeks ago

InspireMD Quarterly report: Q1 2026


InspireMD Reports First Quarter 2026 Financial Results

May 4, 2026, 4:05 PM EDT - 6 weeks ago

InspireMD Reports First Quarter 2026 Financial Results


InspireMD Slides: Investor presentation

May 4, 2026, 4:00 PM EDT - 6 weeks ago

InspireMD Slides: Investor presentation


InspireMD price target lowered to $4 from $5 at Lake Street

2026-05-04T13:51:18.000Z - 6 weeks ago

InspireMD price target lowered to $4 from $5 at Lake Street


InspireMD withdrawing prior FY26 revenue guidance

2026-05-04T13:50:39.000Z - 6 weeks ago

InspireMD withdrawing prior FY26 revenue guidance


InspireMD to Announce First Quarter 2026 Financial Results

Apr 27, 2026, 4:05 PM EDT - 7 weeks ago

InspireMD to Announce First Quarter 2026 Financial Results


InspireMD Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 7 weeks ago

InspireMD Proxy statement: Proxy filing


InspireMD Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 2 months ago

InspireMD Proxy statement: Proxy filing


InspireMD Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 2 months ago

InspireMD Proxy statement: Proxy filing


InspireMD Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

InspireMD Proxy statement: Proxy filing


InspireMD Earnings Call Transcript: Q4 2025

Mar 18, 2026, 8:30 AM EDT - 3 months ago

InspireMD Earnings Call Transcript: Q4 2025


InspireMD Annual report: Q4 2025

Mar 18, 2026, 8:30 AM EDT - 3 months ago

InspireMD Annual report: Q4 2025


InspireMD Earnings release: Q4 2025

Mar 18, 2026, 8:30 AM EDT - 3 months ago

InspireMD Earnings release: Q4 2025


InspireMD reports Q4 EPS (14c), consensus (19c)

2026-03-18T11:11:13.000Z - 3 months ago

InspireMD reports Q4 EPS (14c), consensus (19c)


InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M

2026-03-18T11:10:33.000Z - 3 months ago

InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M


InspireMD participates in a conference call with Lake Street

2026-02-12T15:11:44.000Z - 4 months ago

InspireMD participates in a conference call with Lake Street


InspireMD initiated with a Buy at Maxim

2026-02-02T12:45:07.000Z - 4 months ago

InspireMD initiated with a Buy at Maxim


InspireMD reports inducement grants under Nasdaq listing rule

2026-01-20T14:05:16.000Z - 5 months ago

InspireMD reports inducement grants under Nasdaq listing rule


InspireMD announces publication of C-GUARDIANS trial

2026-01-12T14:20:11.000Z - 5 months ago

InspireMD announces publication of C-GUARDIANS trial


InspireMD announces publication of CREST-2 data in NEJM

2025-11-24T12:45:11.000Z - 7 months ago

InspireMD announces publication of CREST-2 data in NEJM


InspireMD reports inducement grants under Nasdaq listing rule

2025-11-21T14:05:27.000Z - 7 months ago

InspireMD reports inducement grants under Nasdaq listing rule


InspireMD Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:30 AM EST - 7 months ago

InspireMD Earnings Call Transcript: Q3 2025


InspireMD Quarterly report: Q3 2025

Nov 4, 2025, 8:30 AM EST - 7 months ago

InspireMD Quarterly report: Q3 2025


InspireMD Earnings release: Q3 2025

Nov 4, 2025, 8:30 AM EST - 7 months ago

InspireMD Earnings release: Q3 2025


InspireMD reports Q3 EPS (17c) vs (16c) last year

2025-11-04T12:15:34.000Z - 7 months ago

InspireMD reports Q3 EPS (17c) vs (16c) last year


InspireMD Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 7:00 AM EST - 7 months ago

InspireMD Reports Third Quarter 2025 Financial Results


InspireMD names Peter Soukas as Chief Medical Officer

2025-11-03T12:42:01.000Z - 8 months ago

InspireMD names Peter Soukas as Chief Medical Officer


InspireMD Names Peter A. Soukas, M.D.

Nov 3, 2025, 7:30 AM EST - 8 months ago

InspireMD Names Peter A. Soukas, M.D.


InspireMD to Announce Third Quarter 2025 Financial Results

Oct 21, 2025, 4:05 PM EDT - 8 months ago

InspireMD to Announce Third Quarter 2025 Financial Results


InspireMD Registration statement: Registration Filing

Aug 6, 2025, 8:00 AM EDT - 11 months ago

InspireMD Registration statement: Registration Filing


InspireMD Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

InspireMD Earnings Call Transcript: Q2 2025


InspireMD Earnings release: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

InspireMD Earnings release: Q2 2025


InspireMD Quarterly report: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

InspireMD Quarterly report: Q2 2025


InspireMD Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 8:00 AM EDT - 11 months ago

InspireMD Reports Second Quarter 2025 Financial Results


InspireMD Announces Combined Financings of $58 Million

Jul 31, 2025, 8:30 AM EDT - 11 months ago

InspireMD Announces Combined Financings of $58 Million


InspireMD to Announce Second Quarter 2025 Financial Results

Jul 22, 2025, 7:00 AM EDT - 11 months ago

InspireMD to Announce Second Quarter 2025 Financial Results


InspireMD Earnings Call Transcript: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

InspireMD Earnings Call Transcript: Q1 2025


InspireMD Earnings release: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

InspireMD Earnings release: Q1 2025


InspireMD Quarterly report: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

InspireMD Quarterly report: Q1 2025


InspireMD Reports First Quarter 2025 Financial Results

May 9, 2025, 7:00 AM EDT - 1 year ago

InspireMD Reports First Quarter 2025 Financial Results


InspireMD to Announce First Quarter 2025 Financial Results

Apr 25, 2025, 9:00 AM EDT - 1 year ago

InspireMD to Announce First Quarter 2025 Financial Results


InspireMD Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

InspireMD Proxy statement: Proxy Filing


InspireMD Proxy statement: Proxy Filing

Apr 15, 2025, 8:00 AM EDT - 1 year ago

InspireMD Proxy statement: Proxy Filing


InspireMD Registration statement: Registration Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

InspireMD Registration statement: Registration Filing


InspireMD Earnings Call Transcript: Q4 2024

Mar 12, 2025, 8:30 AM EDT - 1 year ago

InspireMD Earnings Call Transcript: Q4 2024


InspireMD Earnings release: Q4 2024

Mar 12, 2025, 8:30 AM EDT - 1 year ago

InspireMD Earnings release: Q4 2024


InspireMD Annual report: Q4 2024

Mar 12, 2025, 8:30 AM EDT - 1 year ago

InspireMD Annual report: Q4 2024


InspireMD Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

InspireMD Earnings Call Transcript: Q3 2024


InspireMD Earnings release: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

InspireMD Earnings release: Q3 2024


InspireMD Quarterly report: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

InspireMD Quarterly report: Q3 2024


InspireMD Earnings Call Transcript: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

InspireMD Earnings Call Transcript: Q2 2024


InspireMD Quarterly report: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

InspireMD Quarterly report: Q2 2024


InspireMD Earnings release: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

InspireMD Earnings release: Q2 2024


InspireMD Earnings Call Transcript: Q1 2024

May 14, 2024, 8:30 AM EDT - 2 years ago

InspireMD Earnings Call Transcript: Q1 2024


InspireMD Quarterly report: Q1 2024

May 14, 2024, 8:30 AM EDT - 2 years ago

InspireMD Quarterly report: Q1 2024


InspireMD Earnings release: Q1 2024

May 14, 2024, 8:30 AM EDT - 2 years ago

InspireMD Earnings release: Q1 2024


InspireMD Proxy statement: Proxy Filing

Apr 18, 2024, 8:00 AM EDT - 2 years ago

InspireMD Proxy statement: Proxy Filing


InspireMD Proxy statement: Proxy Filing

Apr 18, 2024, 8:00 AM EDT - 2 years ago

InspireMD Proxy statement: Proxy Filing


InspireMD Earnings Call Transcript: Q4 2023

Mar 6, 2024, 8:30 AM EST - 2 years ago

InspireMD Earnings Call Transcript: Q4 2023


InspireMD Earnings release: Q4 2023

Mar 6, 2024, 8:30 AM EST - 2 years ago

InspireMD Earnings release: Q4 2023


InspireMD Annual report: Q4 2023

Mar 6, 2024, 8:30 AM EST - 2 years ago

InspireMD Annual report: Q4 2023


Capital_Gains_X
Capital_Gains_X Jun. 15 at 3:30 PM
$NSPR volume is way up this morning...
0 · Reply
BioBuddha
BioBuddha Jun. 15 at 3:16 PM
$NSPR lol people are trying to dump a stock that is already in dumpster.
1 · Reply
Thespectator
Thespectator Jun. 15 at 3:15 PM
$NSPR brand new ATL unlocked today, congrats perma bulls!
0 · Reply
HermesHedges
HermesHedges Jun. 15 at 2:32 PM
0 · Reply
Jonnie5
Jonnie5 Jun. 13 at 4:49 AM
$NSPR 5+ year hold of slow Chinese water torture.
1 · Reply
Thespectator
Thespectator Jun. 12 at 10:09 PM
$NSPR hah every pr was solely benefitting the great management team, surely they deserve every penny!
0 · Reply
arcuy
arcuy Jun. 12 at 9:49 PM
$NSPR sold everything. Hold this since 2019-2020. Not anymore
2 · Reply
focafoca99
focafoca99 Jun. 12 at 8:23 PM
$NSPR grants inducement stock awards to six new non-executive employees under Nasdaq Rule 5635(c)(4). https://www.rapidticker.com/news/nspr-inspiremd-announces-inducement-grants-under-380010
0 · Reply
Jackedtothetits42
Jackedtothetits42 Jun. 11 at 2:21 PM
$NSPR amazing results, will still be red eod
0 · Reply
focafoca99
focafoca99 Jun. 11 at 1:21 PM
$NSPR initiated a 30‑day results update from the CGUARDIANS II trial, showing 100% acute device success and zero major adverse events. https://www.rapidticker.com/news/nspr-inspiremd-announces-30-day-results-d039a7
0 · Reply
BioBuddha
BioBuddha Jun. 11 at 12:57 PM
$NSPR who else did not sell or rather who else bought 😆😆😆😆😆 Absolutely fucking perfect results. 100% success no errors no deaths no strokes no thrombosis no nothing
1 · Reply
focafoca99
focafoca99 Jun. 11 at 12:34 PM
$NSPR updated investors with 30‑day results from the CGUARDIANS II trial of the CGuard Prime 80 cm implant. https://www.rapidticker.com/news/nspr-sec-filing-07d03f
0 · Reply
DARKP00L
DARKP00L Jun. 11 at 12:16 PM
$NSPR 08:08 on Jun. 11 2026 InspireMD Announces 30-Day Outcomes From CGUARDIANS II Clinical Trial Of CGuard Prime 80cm Implant For Use In Transcarotid Artery Revascularization Procedures #tradeideas
0 · Reply
jucebot
jucebot Jun. 10 at 7:18 PM
Jovanotti jumped into a long on $LUD @ $4.38 $BQ $FTRK $HCAI $NSPR
0 · Reply
jucebot
jucebot Jun. 10 at 7:17 PM
Jovanotti grabbed a long position in $FTRK @ $0.53 $BQ $HCAI $NSPR
0 · Reply
jucebot
jucebot Jun. 10 at 7:13 PM
Jovanotti just got long on $NSPR @ $0.80 $BQ
0 · Reply
LoyalShark
LoyalShark Jun. 10 at 1:59 PM
$NSPR PROOF InspireMD's CEO SUCKS.
0 · Reply
LoyalShark
LoyalShark Jun. 10 at 1:47 PM
$NSPR At these levels......if YOU are trying to instil confidence into the market....you would expect to see what ? byt the company insiders ?? Buying. Insider buying in the OPEN MARKET . Anyone seeing any of that???
0 · Reply
LoyalShark
LoyalShark Jun. 10 at 1:38 PM
$NSPR I have never seen a company with so much potential blow it like InspireMd has. The stock is imploding. WHICH means DILUTION is rising. BY not taking care of their 'currency" ..their stock ...they have allowed the currency to devalue in an insane way. THAT is the responsibilty of the CEO. Take care of your currency is job #1. You do that by executing marketing at a higher level. Communicating your story at a higher level. Communicating with shareholders at a higher level. CONFIDENCE is money. CONFIDENCE is everything in the markets. Right now the market is saying -- Mr CEO - you fked up big. YOU did not have the company's back insuring that the only product we had to sell ..could be sold. The UNITED STATES was what you have hung your hat on ....and it is NOW a disaster.
1 · Reply
JBinLB
JBinLB Jun. 10 at 1:23 PM
$NSPR glad I flushed this turd a whole $1 ago
2 · Reply
LoyalShark
LoyalShark Jun. 10 at 1:14 PM
$NSPR disaster.
0 · Reply
IPO_Master
IPO_Master Jun. 10 at 12:53 PM
$NSPR nice
0 · Reply